Cas:2345-61-1 TRANS-3-CHLOROACRYLIC ACID manufacturer & supplier

We serve Chemical Name:TRANS-3-CHLOROACRYLIC ACID CAS:2345-61-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

TRANS-3-CHLOROACRYLIC ACID

Chemical Name:TRANS-3-CHLOROACRYLIC ACID
CAS.NO:2345-61-1
Synonyms:TRANS-3-CHLOROPROPENOIC ACID;trans-3-Chloroacrylic acid;cis-3-chloro acrylic acid;3-cischloroacrylic acid;3-chloroarylic acid;MFCD00064237;Acrylic acid, 3-chloro-, trans-;(e)-3-chloro-2-propenoicacid;(2E)-3-Chloro-2-propenoic acid;EINECS 219-070-0
Molecular Formula:C3H3ClO2
Molecular Weight:106.50800
HS Code:

Physical and Chemical Properties:
Melting point:82-85ºC
Boiling point:192.3ºC at 760mmHg
Density:1.371g/cm3
Index of Refraction:1.4100 (estimate)
PSA:37.30000
Exact Mass:105.98200
LogP:0.82350

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3261 8/PG 2
Packing Group:II


Contact us for information like TRANS-3-CHLOROPROPENOIC ACID chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 219-070-0 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(e)-3-chloro-2-propenoicacid Use and application,trans-3-Chloroacrylic acid technical grade,usp/ep/jp grade.


Related News: Roche’s second anti-tau antibody UCB0107, partnered with UCB, is also slated to enter deeper testing this year. Tau had appeared to have fresh promise as a rival of sorts to amyloid. Tau theory goes that neurofibrillary tangles that form inside cells clog up the brain, and clearing this can help Alzheimer’s patients. TRANS-3-CHLOROACRYLIC ACID manufacturer Compared to white women, Black women are more likely to be diagnosed with breast cancer before age 50 or with estrogen receptor (ER)-negative and triple-negative breast cancer. TRANS-3-CHLOROACRYLIC ACID supplier Advanced clinical trials with the Company��s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS. TRANS-3-CHLOROACRYLIC ACID vendor The Biogen Inc (BIIB.O) drug, Aduhelm, was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer’s, rather than proof that it slows progression of the lethal mind-wasting disease. TRANS-3-CHLOROACRYLIC ACID factory Roche’s second anti-tau antibody UCB0107, partnered with UCB, is also slated to enter deeper testing this year. Tau had appeared to have fresh promise as a rival of sorts to amyloid. Tau theory goes that neurofibrillary tangles that form inside cells clog up the brain, and clearing this can help Alzheimer’s patients.